isomethyleugenol has been researched along with Bone Marrow Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bench, AJ; Delabesse, E; Deloukas, P; Fourouclas, N; Green, AR; Hunt, AR; Huntly, BJ; Li, J | 1 |
| Al-Ismail, D; Richard, VS; Salamat, A | 1 |
| Horie, S; Miyata, T; Nakanishi, H; Saotome, S; Tanaka, T | 1 |
3 other study(ies) available for isomethyleugenol and Bone Marrow Diseases
| Article | Year |
|---|---|
Characterization of the imprinted polycomb gene L3MBTL, a candidate 20q tumour suppressor gene, in patients with myeloid malignancies.
Topics: Alternative Splicing; Bone Marrow Diseases; Case-Control Studies; Chromosomal Proteins, Non-Histone; Chromosome Deletion; CpG Islands; DNA Mutational Analysis; Gene Expression; Genes, Tumor Suppressor; Humans; Methylation; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasm Proteins; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sequence Alignment; Tumor Suppressor Proteins | 2004 |
Should we test TPMT enzyme levels before starting azathioprine?
Topics: Aged; Arthritis, Rheumatoid; Azathioprine; Bone Marrow Diseases; Diagnostic Tests, Routine; Female; Homozygote; Humans; Immunosuppressive Agents; Inactivation, Metabolic; Mercaptopurine; Methylation; Methyltransferases; Neutropenia; Prodrugs; Sepsis; United Kingdom | 2007 |
[Evaluation of methylated collagen gel as a hemostatic agent for bone marrow bleeding using canine (author's transl)].
Topics: Animals; Bone Marrow Diseases; Collagen; Dogs; Female; Gels; Hemorrhage; Hemostatics; Humans; Male; Methylation; Middle Aged | 1980 |